Blog 4 Essential KPIs for Gene Therapy Treatment August 27, 2024 Gene therapy holds the promise to revolutionize medicine, particularly for patients with rare and genetic disorders. But how do patient… Read More
Blog How Emerging Technology is Transforming Medication Adherence August 21, 2024 The Challenge of Medication Non-Adherence in Specialty Pharmacy Medication adherence refers to whether patients take their medications as prescribed, including… Read More
Blog Power of Biopharma Partnerships: GSK and Flagship Pioneering August 6, 2024 Introduction In the fast-paced world of biopharma, partnerships can drive remarkable advancements. GlaxoSmithKline (GSK), a global healthcare leader, is taking… Read More
Blog Eli Lilly’s Urgent Push for Alzheimer’s Treatment Revolution July 30, 2024 Introduction In the tough terrain of finding an Alzheimer’s cure, Eli Lilly is setting the pace with their latest innovation… Read More
Blog Pfizer’s Bold Move in the Obesity Drug Market July 16, 2024 Within a sector populated by many market pioneers promoting injectable solutions, Pfizer is redefining the landscape with an oral medication… Read More
Blog Unlocking Competitive Data Insights in Therapy Basket Fill Rates July 9, 2024 In the biopharma industry, understanding how your therapy basket’s fill rate stacks up against competitors can be a game-changer. This… Read More
Blog The Revolutionary Rise of Cell Therapy Trials July 3, 2024 Picture a future in which we don’t merely manage symptoms but eliminate diseases at their roots. This future isn’t a… Read More
Blog AstraZeneca’s Calquence Sets New Standard for Lymphoma June 25, 2024 Mantle cell lymphoma (MCL) is a rare yet aggressive form of non-Hodgkin lymphoma, and treatment options have been limited for… Read More
Blog FDA Draft Guidance: Fast-Track Cell and Gene Therapies June 18, 2024 The FDA unveiled a much-anticipated draft guide, outlining how businesses can secure approvals for platform technologies. This regulatory advance has… Read More
Blog AstraZeneca Aims for $80 Billion Revenue by 2030 June 4, 2024 AstraZeneca is experiencing tremendous success and progress under the leadership of CEO Pascal Soriot. His current objective is to achieve… Read More
Blog FDA Approves Amgen’s First Interchangeable Biosimilar June 1, 2024 The U.S. Food and Drug Administration (FDA) has given the green light to Amgen’s monoclonal antibody Bkemv, the first interchangeable… Read More
Blog GSK’s New Asthma Drug Clears Two Phase 3 Trials May 29, 2024 Tuesday brought good news for asthma sufferers and the healthcare community alike, courtesy of GSK. The pharmaceutical firm announced the… Read More